Market Tracker

11/17 5:15pm ET

TherapeuticsMD Inc (NASDAQ:TXMD)

5.85
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
3.50
Today|||52-Week Range
8.30
+1.39%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close5.85
Today’s open5.92
Day’s range5.75 - 6.01
Volume2,672,938
Average volume (3 months)3,066,227
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book9.03

Competitors

 Today’s
change
Today’s
% change
AKCAAkcea Therapeutics I...0.000.00%
ESPREsperion Therapeutic...0.000.00%
BHVNBiohaven Pharmaceuti...0.000.00%
FWPForward Pharma A/S0.000.00%
Data as of 4:01pm ET, 11/17/2017

Financials

Next reporting dateFebruary 22, 2018
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts